Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Q1 2026 Earnings Call Transcript May 13, 2026
Milestone Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.03.
Operator: Ladies and gentlemen, good morning, and welcome to the Milestone Pharma First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Michael Wood of LifeSci Advisors. Please...
